Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00680550
Other study ID # CMD 466
Secondary ID
Status Completed
Phase N/A
First received May 15, 2008
Last updated October 15, 2013
Start date April 2008
Est. completion date April 2013

Study information

Verified date October 2013
Source Medtronic BRC
Contact n/a
Is FDA regulated No
Health authority Germany: Federal Institute for Drugs and Medical Devices
Study type Observational

Clinical Trial Summary

To describe the clinical indications for Reveal XT in diagnosis and continuous monitoring of arrhythmia and to explore the clinical applications and outcome of arrhythmia monitoring on patient care.


Description:

Improving the diagnosis and management of cardiac rhythm disturbances remains a major challenge for physicians. Limitations of current cardiac arrhythmia monitoring using ECG, holters or event recorders are that these methods are non-continuous and/or automatic arrhythmia detection is often impossible. The Medtronic Reveal XT Insertable Cardiac Monitor is a programmable device which continuously monitors the patient's subcutaneous ECG and provides information regarding arrhythmia episodes, long term trending of AF burden, patient's activity and heart rate variability. The Reveal XT records cardiac information in response to patient activation and automatically detected arrhythmias thereby offering advantages over conventional tools for long-term arrhythmia monitoring with regard to compliance and recording time.

The clinical applications for Reveal XT are varied. Diagnostic, arrhythmia monitoring and arrhythmia management functions can be discriminated.

This study is a prospective, observational, multicenter international post-market study. The results of this study will describe the different patient groups for which the Reveal XT is being used for the diagnosis and monitoring of various cardiac arrhythmias. This study will also collect data regarding the clinical consequences of using the Reveal XT and the influence of Reveal XT data on clinical care pathways. The physician as well as the patient's satisfaction with the device will be evaluated. The study will be conducted in 60-100 centers primarily in Europe. It is expected that 800-1000 patients will be enrolled.


Recruitment information / eligibility

Status Completed
Enrollment 1003
Est. completion date April 2013
Est. primary completion date April 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient implanted or scheduled for an implant with a Reveal XT Insertable Cardiac Monitor System for arrhythmia diagnosis or monitoring

- Patient must be willing to sign a Patient Data Release Form (or Informed Consent where applicable)

Exclusion Criteria:

- Enrollment outside a 30-day window from the planned/performed Reveal XT implant procedure (from 15 days pre-implant until 15 days post implant)

- Patient is implanted with a pacemaker, ICD, CRT-device or an implantable hemodynamic monitoring system

- Unwillingness or inability to cooperate or give written informed consent or, if the patient is a minor and the legal guardian refuses to give consent

Study Design

Time Perspective: Prospective


Locations

Country Name City State
Austria Krankenhaus der Elisabethinen Linz
Austria Klinkum Wels-Grieskirchen GmbH Wels
Austria Universitätsklinik für Innere Medizin Wien
Belarus Republican Scientific Practical Center Minsk
Czech Republic Fakultni nemocnice Brno Brno
Czech Republic Fakultni nemocnice u sv. Anny v Brne Brno
Czech Republic Kardiologicka ambulance Ostrava
Finland Tampere University Hospital Tampere
Germany Zentralklinik Bad Berka Bad Berka
Germany St.-Marien-Hospital Bonn-Venusberg
Germany Kardiologische Praxis Burg
Germany Klinikum Coburg Coburg
Germany Kardiologische Praxis Dessau
Germany Herzzentrum Dresden Dresden
Germany Kardiocentrum Frankfurt
Germany Universitatsklinikum Freiburg
Germany St. Johannes Hospital Hagen
Germany Universitares Herzzentrum Hamburg
Germany Asklepios Klinik Hamburg-Harburg
Germany Medizinische Hochshule Hannover
Germany Uniklinik Homburg - Klinik fur Innere Medizin III Homburg
Germany Herzzentrum, University of Leipzig Leipzig
Germany Klinik Augustinum München
Germany Klinikum der Universität München-Großhadern (LMU) München
Germany Universitätsklinikum Münster Münster
Germany Klinikum Nürnberg Süd Nürnberg
Germany St. Martinus Hospital Olpe
Germany DRK-Krankenhaus Mölln-Ratzeburg Ratzeburg
Germany Krankenhaus Barmherzige Brueder Regensburg
Germany Krankenhaus Reinbek, St.-Adolf-Stift Reinbek
Germany Universitaetsklinikum Tuebingen Tuebingen
Italy Azienda Ospedaliera Universitaria Careggi Florence
Netherlands Gelre Apeldoorn Apeldoorn
Netherlands Ziekenhuis De Tjongerschans Heerenveen
Netherlands Bethesda Ziekenhuis Hoogeveen
Netherlands Westfries Gasthuis Hoorn
Netherlands Medisch Centrum Leeuwarden Leeuwarden
Netherlands Vlietland Ziekenhuis Schiedam
Netherlands Maasland Ziekenhuis Sittard
Netherlands Diakonessenhuis Utrecht Utrecht
Portugal Centro Hospitalar do Porto - Hospital de Santo Antonio Porto
Russian Federation Scientific Research Center of Cardio Vascular Surgery by A.N. Bakulev Moscow
Russian Federation State Research Institute of Circulation Pathology Novosibirsk
Russian Federation Almazov Federeal Heart, Blood and Endocrinology Centre St. Petersburg
Russian Federation Tyumen Cardiology Centre Tyumen
Slovakia Arytmologicke oddelenie VUSCH Kosice
Slovenia University Medical Center Ljubljana Ljubljana
Spain Complejo Hospitalario Universitario de Vigo Vigo
Sweden University Hospital Örebro Örebro
Switzerland Hopital Cantonal de Fribourg Fribourg
Switzerland Hopital Cantonal Universitaires de Geneve Geneve
Switzerland Hopital de Pourtales de Neuchatel Neuchatel
Switzerland Hopital de Sion CHCVS Sion
Switzerland UniversitatsSpital Zurich
United Arab Emirates Sheikh Khalifa Medical Center Abu Dhabi
United Kingdom Liverpool Heart and Chest Hospital Liverpool

Sponsors (1)

Lead Sponsor Collaborator
Medtronic BRC

Countries where clinical trial is conducted

Austria,  Belarus,  Czech Republic,  Finland,  Germany,  Italy,  Netherlands,  Portugal,  Russian Federation,  Slovakia,  Slovenia,  Spain,  Sweden,  Switzerland,  United Arab Emirates,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary descriptive: clinical indications for Reveal XT To describe the patient population implanted with a Reveal XT for arrhythmia diagnosis and monitoring 2008-2012 No
See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Terminated NCT04115735 - His Bundle Recording From Subclavian Vein
Completed NCT04571385 - A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF) Phase 2
Completed NCT05366803 - Women's Health Initiative Silent Atrial Fibrillation Recording Study N/A
Completed NCT02864758 - Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
Recruiting NCT05442203 - Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease N/A
Completed NCT05599308 - Evaluation of Blood Pressure Monitor With AFib Screening Feature N/A
Completed NCT03790917 - Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
Enrolling by invitation NCT05890274 - Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO N/A
Recruiting NCT05266144 - Atrial Fibrillation Patients Treated With Catheter Ablation
Recruiting NCT05316870 - Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation N/A
Not yet recruiting NCT06023784 - The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Recruiting NCT04092985 - Smart Watch iECG for the Detection of Cardiac Arrhythmias
Completed NCT04087122 - Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures N/A
Completed NCT06283654 - Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
Recruiting NCT05416086 - iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study N/A
Completed NCT05067114 - Solutions for Atrial Fibrillation Edvocacy (SAFE)
Completed NCT04546763 - Study Watch AF Detection At Home
Completed NCT03761394 - Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke N/A